查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734835

2032 年生理食盐水市场预测：按类型、容器类型、产量、应用、最终用途和地区进行的全球分析

Normal Saline for Parenteral Use Market Forecasts to 2032 - Global Analysis By Type (Plastic Bottles and Glass Bottles), Container Type, Volume, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生理食盐水市场预计在 2025 年达到 36 亿美元，到 2032 年将达到 64 亿美元，预测期内的复合年增长率为 7.5%。

生理食盐水是用于静脉治疗的无菌等渗溶液，其中含有 0.9% 的氯化钠。恢復体液平衡、维持血压并在临床环境中给药。它在生理上等同于血浆，最大限度地减少输注过程中的细胞损伤。生理食盐水是紧急医疗、外科手术和脱水的基石，确保世界各地的医院和救护车对患者照护。

根据美国国家生物技术资讯中心的数据，美国每年销售约 2 亿公升生理食盐水。此外，全球每天向患者註射超过一百万公升0.9％的氯化钠。

全球手术数量正在增加

全球范围内外科手术数量的增加推动了对生理食盐水重要静脉注射液的需求。需要手术介入的慢性病盛行率不断上升，推动着市场的成长。微创手术的进步增加了对可靠补水解决方案的需求。新兴市场的医疗保健基础设施不断扩大将支持外科手术的增加。政府改善外科治疗服务的措施将增加市场潜力。世界人口老化导致外科手术需求增加。

严格的监管要求

生理食盐水的生产和分销的严格规定增加了合规成本。製造设施的核准流程复杂，阻碍了市场进入。严格的品管标准需要大量的技术投资。不同地区有不同的规定，这使得全球供应链变得复杂。违规可能会导致产品召回并损害品牌声誉。配方调整的弹性有限阻碍了创新。

开发创新包装解决方案

包装方面的创新，例如环保和防篡改设计，正在为市场扩张创造机会。先进的包装可提高产品安全性、保质期并吸引医疗保健提供者。人们对便携式、易于生理食盐水输送系统的需求日益增加。与包装技术公司的合作加速了产品开发。对永续包装的监管支持推动了投资。一次性无菌包装的趋势将增加市场吸引力。这些进步将提高不同医疗保健环境中的可近性和采用率。

原物料价格波动

氯化钠、无菌水等原物料价格的波动影响生产成本。供应链中断将加剧价格波动并影响盈利。对有限数量供应商的依赖增加了对市场衝击的脆弱性。灭菌过程的能源成本上升增加了财务负担。不可预测的定价使与医疗保健提供者的长期合约变得复杂。缺乏多样化的筹资策略会增加风险。

COVID-19的影响：

由于住院人数和重症患者人数增加， COVID-19 疫情导致生理食盐水需求激增。供应链中断导致原材料交付延迟，影响生产。随着远端医疗的增加，生理食盐水减少。然而，疫苗接种宣传活动和医疗紧急情况刺激了市场需求。疫情期间生产成本上升影响了人们的负担能力。这场疫情凸显了可靠输注的重要性，并为投资提供了动力。预计疫情过后外科手术的復苏将维持市场成长。

预计塑胶瓶市场在预测期内将占据最大份额

由于塑胶瓶在医院中广泛用于安全、便捷地供应生理食盐水，预计在预测期内将占据最大的市场占有率。塑胶瓶具有耐用性且易于操作，可提高业务效率。无菌製造技术的进步确保了产品的安全性和合规性。塑胶瓶的成本效益将推动其在註重预算的市场中的应用。医用塑胶的监管核准正在增强市场信心。它在外科手术和急救应用中的多功能性将增强市场占有率。

预计在预测期内，软袋领域将出现最高的复合年增长率。

由于其轻量化设计和在医疗保健环境中节省空间的优势，预计柔性袋领域将在预测期内实现最高的成长率。柔性袋降低了储存和运输成本，因此对医院很有吸引力。防篡改和环保袋设计的创新将会增加其采用率。由于门诊病人和居家医疗的增加，对便携式生理食盐水的需求也在增加。对永续包装的监管支持有助于推动该领域的扩张。与物流公司合作可以优化配送效率。关注患者的便利性将推动这一领域的成长。

占比最高的地区：

预计亚太地区将在预测期内占据最大的市场占有率。这是因为中国和印度等国家拥有强大的医疗保健产业和大量的手术。人口的快速增长和慢性疾病的增加正在推动对生理食盐水的需求。政府对医疗保健基础设施的投资正在支持市场成长。主要製造商的存在增强了区域主导地位。外科手术治疗机会的增加推动了生理食盐水的使用。可支配收入的增加推动了医疗保健支出。

复合年增长率最高的地区：

在预测期内，北美预计将因其先进的医疗保健体系和严格的监管标准而呈现最高的复合年增长率。该地区的手术率很高，对可靠生理食盐水的需求不断增长。包装和运输系统的创新将推动市场成长。大型製药公司的存在推动了产品开发。患者安全意识的增强正在推动其采用。对门诊护理基础设施的投资将支持扩张。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生理食盐水市场（按类型）

  • 宝特瓶
  • 玻璃瓶

6. 全球生理食盐水市场（依容器类型）

  • 软包
  • 硬质瓶子和容器
  • 预填充式注射器
  • 点滴瓶
  • 管瓶
  • 安瓿
  • 其他容器类型

7. 全球生理食盐水市场（按数量）

  • 小容量肠外给药（SVP）
  • 大容量肠外给药（LVP）
  • 其他卷

8. 全球生理食盐水市场（依应用）

  • 肌肉注射
  • 静脉注射
  • 伤口清洗/冲洗

9. 全球生理食盐水市场（依最终用户）

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他最终用户

第十章全球生理食盐水市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Baxter
  • Pfizer
  • B. Braun
  • ICU Medical
  • Fresenius Kabi
  • Otsuka
  • Kelun Group
  • CR Double-Cran
  • SSY Group
  • Cisen Pharmaceutical
  • Denis Chem Lab Limited
  • Advacare Pharma USA, LLC.
  • NIRMA LIMITED
  • Alcare pharmaceuticals pte ltd
  • Sichuan Kelun Pharmaceutical Co., Ltd.
Product Code: SMRC29472

According to Stratistics MRC, the Global Normal Saline for Parenteral Use Market is accounted for $3.6 billion in 2025 and is expected to reach $6.4 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Normal Saline for Parenteral Use is a sterile, isotonic solution of 0.9% sodium chloride in water, used for intravenous (IV) therapy. It restores fluid balance, maintains blood pressure, and delivers medications in clinical settings. As a physiological equivalent to blood plasma, it minimizes cellular damage during infusion. Normal saline is a cornerstone of emergency medicine, surgery, and dehydration treatment, ensuring safe and effective patient care in hospitals and ambulances worldwide.

According to the National Center for Biotechnology Information, in the U.S., around 200 million liters of saline are sold annually. In addition, over 1 million liters of 0.9% sodium chloride are administered to patients across the globe daily.

Market Dynamics:

Driver:

Increasing surgical procedures globally

The rising number of surgical procedures worldwide is fueling demand for normal saline as a critical intravenous fluid. Growing prevalence of chronic diseases requiring surgical interventions drives market growth. Advancements in minimally invasive surgeries increase the need for reliable hydration solutions. Expanding healthcare infrastructure in emerging markets supports higher surgical volumes. Government initiatives to improve access to surgical care enhance market potential. The aging global population contributes to increased surgical needs.

Restraint:

Stringent regulatory requirements

Stringent regulations governing the production and distribution of parenteral saline solutions increase compliance costs. Complex approval processes for manufacturing facilities delay market entry. Strict quality control standards require significant investment in technology. Regulatory variations across regions complicate global supply chains. Non-compliance risks product recalls, damaging brand reputation. Limited flexibility in formulation adjustments hinders innovation.

Opportunity:

Development of innovative packaging solutions

Innovations in packaging, such as eco-friendly and tamper-proof designs, are creating opportunities for market expansion. Advanced packaging enhances product safety and shelf life, appealing to healthcare providers. The demand for portable and user-friendly saline delivery systems is rising. Partnerships with packaging technology firms drive product development. Regulatory support for sustainable packaging encourages investment. The trend toward single-use, sterile packaging boosts market appeal. These advancements improve accessibility and adoption in diverse healthcare settings.

Threat:

Raw material price fluctuations

Fluctuations in the prices of raw materials, such as sodium chloride and sterile water, impact production costs. Supply chain disruptions exacerbate price volatility, affecting profitability. Dependence on limited suppliers increases vulnerability to market shocks. Rising energy costs for sterilization processes add financial strain. Unpredictable pricing complicates long-term contracts with healthcare providers. Lack of diversified sourcing strategies heightens risks.

Covid-19 Impact:

The COVID-19 pandemic surged demand for normal saline due to increased hospitalizations and critical care needs. Supply chain disruptions delayed raw material deliveries, impacting production. The rise in telehealth reduced non-emergency saline use in outpatient settings. However, vaccination campaigns and emergency care boosted market demand. Rising manufacturing costs during the crisis affected affordability. The pandemic underscored the importance of reliable IV fluids, driving investments. Post-pandemic recovery in surgical procedures is expected to sustain market growth.

The plastic bottles segment is expected to be the largest during the forecast period

The plastic Bottles segment is expected to account for the largest market share during the forecast period propelled by their widespread use in hospitals for safe and convenient saline delivery. Plastic bottles offer durability and ease of handling, enhancing operational efficiency. Advances in sterile manufacturing ensure product safety and compliance. The cost-effectiveness of plastic bottles drives adoption in budget-conscious markets. Regulatory approvals for medical-grade plastics bolster market trust. Their versatility across surgical and emergency applications strengthens market share.

The flexible bags segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the flexible bags segment is predicted to witness the highest growth rate driven by their lightweight design and space-saving benefits in healthcare settings. Flexible bags reduce storage and transportation costs, appealing to hospitals. Innovations in tamper-proof and eco-friendly bag designs enhance adoption. The rise in outpatient and home care increases demand for portable saline solutions. Regulatory support for sustainable packaging fuels segment expansion. Partnerships with logistics firms optimize distribution efficiency. The focus on patient convenience propels this segment's growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to its robust healthcare sector and high surgical volumes in countries like China and India. Rapid population growth and rising chronic diseases drive demand for saline. Government investments in healthcare infrastructure support market growth. The presence of key manufacturers strengthens regional dominance. Increasing access to surgical care fuels saline use. Rising disposable incomes enhance healthcare spending.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by advanced healthcare systems and stringent regulatory standards. The region's high surgical procedure rates drive demand for reliable saline solutions. Innovations in packaging and delivery systems enhance market growth. The presence of leading pharmaceutical companies fosters product development. Growing awareness of patient safety boosts adoption. Investments in outpatient care infrastructure support expansion.

Key players in the market

Some of the key players in Normal Saline for Parenteral Use Market include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran, SSY Group, Cisen Pharmaceutical, Denis Chem Lab Limited, Advacare Pharma USA, LLC., NIRMA LIMITED, Alcare Pharmaceuticals Pte Ltd, and Sichuan Kelun Pharmaceutical Co., Ltd.

Key Developments:

In April 2025, Baxter International expanded production of FDA-approved electrolyte-enriched saline solutions with improved stability for critical care, addressing global IV fluid shortages in emergency medicine.

In March 2025, Fresenius Kabi launched premixed saline bags with pH-balancing additives for chemotherapy patients, reducing side effects and simplifying oncology infusion protocols in hospitals.

In February 2025, Kelun Group debuted China's first biodegradable saline IV packaging, cutting plastic waste by 70% while maintaining sterility standards for large-volume parenteral therapies.

Types Covered:

  • Plastic Bottles
  • Glass Bottles

Container Types Covered:

  • Flexible Bags
  • Rigid Bottles And Containers
  • Pre-Filled Syringes
  • IV Infusion Bottles
  • Vials
  • Ampoules
  • Other Container Types

Volumes Covered:

  • Small Volume Parenteral (SVP)
  • Large Volume Parenteral (LVP)
  • Other Volumes

Applications Covered:

  • Intramuscular Injection
  • Intravenous Injection
  • Wound Irrigation/Flush

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Normal Saline for Parenteral Use Market, By Type

  • 5.1 Introduction
  • 5.2 Plastic Bottles
  • 5.3 Glass Bottles

6 Global Normal Saline for Parenteral Use Market, By Container Type

  • 6.1 Introduction
  • 6.2 Flexible Bags
  • 6.3 Rigid Bottles And Containers
  • 6.4 Pre-Filled Syringes
  • 6.5 IV Infusion Bottles
  • 6.6 Vials
  • 6.7 Ampoules
  • 6.8 Other Container Types

7 Global Normal Saline for Parenteral Use Market, By Volume

  • 7.1 Introduction
  • 7.2 Small Volume Parenteral (SVP)
  • 7.3 Large Volume Parenteral (LVP)
  • 7.4 Other Volumes

8 Global Normal Saline for Parenteral Use Market, By Application

  • 8.1 Introduction
  • 8.2 Intramuscular Injection
  • 8.3 Intravenous Injection
  • 8.4 Wound Irrigation/Flush

9 Global Normal Saline for Parenteral Use Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Specialty Clinics
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Other End Users

10 Global Normal Saline for Parenteral Use Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Baxter
  • 12.2 Pfizer
  • 12.3 B. Braun
  • 12.4 ICU Medical
  • 12.5 Fresenius Kabi
  • 12.6 Otsuka
  • 12.7 Kelun Group
  • 12.8 CR Double-Cran
  • 12.9 SSY Group
  • 12.10 Cisen Pharmaceutical
  • 12.11 Denis Chem Lab Limited
  • 12.12 Advacare Pharma USA, LLC.
  • 12.13 NIRMA LIMITED
  • 12.14 Alcare pharmaceuticals pte ltd
  • 12.15 Sichuan Kelun Pharmaceutical Co., Ltd.

List of Tables

  • Table 1 Global Normal Saline for Parenteral Use Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Normal Saline for Parenteral Use Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Normal Saline for Parenteral Use Market Outlook, By Plastic Bottles (2024-2032) ($MN)
  • Table 4 Global Normal Saline for Parenteral Use Market Outlook, By Glass Bottles (2024-2032) ($MN)
  • Table 5 Global Normal Saline for Parenteral Use Market Outlook, By Container Type (2024-2032) ($MN)
  • Table 6 Global Normal Saline for Parenteral Use Market Outlook, By Flexible Bags (2024-2032) ($MN)
  • Table 7 Global Normal Saline for Parenteral Use Market Outlook, By Rigid Bottles And Containers (2024-2032) ($MN)
  • Table 8 Global Normal Saline for Parenteral Use Market Outlook, By Pre-Filled Syringes (2024-2032) ($MN)
  • Table 9 Global Normal Saline for Parenteral Use Market Outlook, By IV Infusion Bottles (2024-2032) ($MN)
  • Table 10 Global Normal Saline for Parenteral Use Market Outlook, By Vials (2024-2032) ($MN)
  • Table 11 Global Normal Saline for Parenteral Use Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 12 Global Normal Saline for Parenteral Use Market Outlook, By Other Container Types (2024-2032) ($MN)
  • Table 13 Global Normal Saline for Parenteral Use Market Outlook, By Volume (2024-2032) ($MN)
  • Table 14 Global Normal Saline for Parenteral Use Market Outlook, By Small Volume Parenteral (SVP) (2024-2032) ($MN)
  • Table 15 Global Normal Saline for Parenteral Use Market Outlook, By Large Volume Parenteral (LVP) (2024-2032) ($MN)
  • Table 16 Global Normal Saline for Parenteral Use Market Outlook, By Other Volumes (2024-2032) ($MN)
  • Table 17 Global Normal Saline for Parenteral Use Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Normal Saline for Parenteral Use Market Outlook, By Intramuscular Injection (2024-2032) ($MN)
  • Table 19 Global Normal Saline for Parenteral Use Market Outlook, By Intravenous Injection (2024-2032) ($MN)
  • Table 20 Global Normal Saline for Parenteral Use Market Outlook, By Wound Irrigation/Flush (2024-2032) ($MN)
  • Table 21 Global Normal Saline for Parenteral Use Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Normal Saline for Parenteral Use Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Normal Saline for Parenteral Use Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 24 Global Normal Saline for Parenteral Use Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 25 Global Normal Saline for Parenteral Use Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.